133 research outputs found
Dampak Budidaya Perikanan di Sungai Kelekar terhadap Struktur Komunitas Makrozoobentos
Kegiatan budidaya dan pemukiman penduduk disekitar Sungai Kelekar ini dapat menyebabkan Perubahan struktur komunitas makrozoobentos yang menandakan adanya pencemaran bahan organik pada sungai tersebut, sehingga perlu dilakukan suatu penelitian diperairan Sungai Kelekar yang bertujuan untuk mengetahui struktur komunitas makrozoobentos, tekstur dan komposisi sedimen di Sungai kelekar sebagai indikator pencemaran bahan organik. Penelitian ini dilaksanakan selama bulan Januari, Februari dan Maret 2014 di 6 stasiun pengamatan. Pada 6 stasiun pengamatan diperoleh 11 jenis makrozoobentos yang tergolong kedalam 5 kelas. Kelas Gastropoda yaitu Melanoides tuberculata, bellamya sumatrensis, Thiara sp, kelas Polychaeta yaitu Nereis sp, kelas Pelecypoda yaitu Corbicula javanica, kelas Oligochaeta yaitu Tubifex sp, Limnodrillus sp, Lumbricullus sp, Branchiura sp, dan kelas Insecta yaitu Larva Chironomous sp, Ephemerella sp. Kelimpahan individu tertinggi pada penelitian ini dari jenis Tubifex sp sebesar 34,5 ind/m2 yaitu dari stasiun 4 pengambilan bulan Februari, kelimpahan relatif tertinggi dari jenis Tubifex sp sebesar 77,6% yaitu dari stasiun 5 pengambilan bulan Februari, indeks keanekaragaman berkisar antara 0,76 – 1,66 (tercemar sedang – tercemar berat), indeks keseragaman berkisar antara 0,76 – 1,69 (keseragaman rendah) dan indeks dominasi berkisar antara 0,22 – 0,63. Tekstur sedimen di Sungai Kelekar ada 2 tipe, yaitu lempung liat berlumpur dan liat berlumpur. Sedangkan kandungan bahan organik sedimen berkisar antara 0,13% - 0,69%. Tingginya jenis makrozoobentos yang toleran terhadap pencemaran perairan seperti jenis Tubifex sp pada stasiun 3 dan stasiun 4 menggambarkan bahwa perairan di sekitar stasiun pengamatan tersebut tergolong kedalam perairan yang tercemar. Hal ini disebabkan karena adanya aktifitas budidaya perikanan dan limbah kegiatan rumah tangga yang ada disekitar stasiun tersebut
PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants
The Summary Altogether 95 children with primary bone fragility were screened for variants in PLS3, the gene underlying X-linked osteoporosis. Two children with multiple peripheral and spinal fractures and low BMD had novel disease-causing PLS3 variants. Children with milder phenotypes had no pathogenic variants. PLS3 screening is indicated in childhood-onset primary osteoporosis. Introduction The study aimed to determine the role of pathogenic PLS3 variants in children's bone fragility and to elucidate the associated phenotypic features. Methods Two cohorts of children with bone fragility were screened for variants in PLS3, the gene underlying X-linked osteoporosis. Cohort I comprised 31 patients with childhood-onset primary osteoporosis of unknown etiology. Cohort II comprised 64 children who had sustained multiple fractures but were otherwise healthy. Clinical and radiological data were reviewed. Peripheral blood DNA was Sanger sequenced for coding exons and flanking intronic regions of PLS3. Results In two patients of cohort I, where other common genetic causes had been excluded, we identified two novel disease-causing PLS3 variants. Patient 1 was a male with bilateral femoral fractures at 10 years, low BMD (Z-score -4.1; 18 years), and multiple vertebral compression fractures. He had a novel nonsense variant in PLS3. Patient 2 was a girl with multiple long bone and vertebral fractures and low BMD (Z-score -6.6 at 6 years). She had a de novo missense variant in PLS3; whole exome sequencing and array-CGH identified no other genetic causes. Iliac crest bone biopsies confirmed low-turnover osteoporosis in both patients. In cohort II, no pathogenic PLS3 variants were identified in any of the subjects. Conclusion Two novel disease-causing variants in PLS3 were identified in a boy and a girl with multiple peripheral and spinal fractures and very low BMD while no pathogenic variants were identified in children with less severe skeletal fragility. PLS3 screening is warranted in male and female patients with childhood-onset primary osteoporosis.Peer reviewe
Communicating the amount of windstorm induced forest damage by the maximum wind gust speed in Finland
Windstorms are natural disturbance agents in forests playing a role in
natural forest regeneration. In Finland, the most severe individual
windstorms have commonly damaged 2–4 million m3 of timber. In addition
to financial losses caused to forest owners, windthrown trees have in many
cases seriously disrupted the functionality of the national power grid.
Communicating windstorm risks in duty forecasting is difficult. In this
study, we aimed at developing windstorm impact estimates for forest damage in
Finland to help the forecaster to improve communication of the risks of
windstorms. We have compared the volume of forest damage caused by the most
intense windstorms in Finland during the recent decade to the observed
maximum inland wind gust speeds associated with the same windstorms. It was
found out that the volume of forest damage follows approximately a power
relation as a function of wind gust speed with a power of ∼10. This is
a tentative estimate because of a short time series and small number of
inspected windstorms. Moreover, also wind direction, location of the affected
area and soil properties among other factors have an impact to the amount of
damage as illustrated in our inspection. Despite the shortness of the time
series, we believe that our results demonstrating the steep increase in the
impacts of windstorms with an increasing windstorm intensity are valuable.
However, more detailed investigations with longer time series are needed in
order to more specifically communicate the windstorm risks and their impacts
in boreal forests.</p
Impaired Bone Health in Inflammatory Bowel Disease: A Case-Control Study in 80 Pediatric Patients
Peer reviewe
PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants
An approach for the identification of targets specific to bone metastasis using cancer genes interactome and gene ontology analysis
Metastasis is one of the most enigmatic aspects of cancer pathogenesis and is
a major cause of cancer-associated mortality. Secondary bone cancer (SBC) is a
complex disease caused by metastasis of tumor cells from their primary site and
is characterized by intricate interplay of molecular interactions.
Identification of targets for multifactorial diseases such as SBC, the most
frequent complication of breast and prostate cancers, is a challenge. Towards
achieving our aim of identification of targets specific to SBC, we constructed
a 'Cancer Genes Network', a representative protein interactome of cancer genes.
Using graph theoretical methods, we obtained a set of key genes that are
relevant for generic mechanisms of cancers and have a role in biological
essentiality. We also compiled a curated dataset of 391 SBC genes from
published literature which serves as a basis of ontological correlates of
secondary bone cancer. Building on these results, we implement a strategy based
on generic cancer genes, SBC genes and gene ontology enrichment method, to
obtain a set of targets that are specific to bone metastasis. Through this
study, we present an approach for probing one of the major complications in
cancers, namely, metastasis. The results on genes that play generic roles in
cancer phenotype, obtained by network analysis of 'Cancer Genes Network', have
broader implications in understanding the role of molecular regulators in
mechanisms of cancers. Specifically, our study provides a set of potential
targets that are of ontological and regulatory relevance to secondary bone
cancer.Comment: 54 pages (19 pages main text; 11 Figures; 26 pages of supplementary
information). Revised after critical reviews. Accepted for Publication in
PLoS ON
Fast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts
Background: Prostate tumours are commonly poorly oxygenated which is associated with tumour progression and development of resistance to chemotherapeutic drugs and radiotherapy. Fibroblast growth factor 8b (FGF8b) is a mitogenic and angiogenic factor, which is expressed at an increased level in human prostate tumours and is associated with a poor prognosis. We studied the effect of FGF8b on tumour oxygenation and growth parameters in xenografts in comparison with vascular endothelial growth factor (VEGF)-expressing xenografts, representing another fast growing and angiogenic tumour model. Methods: Subcutaneous tumours of PC-3 cells transfected with FGF8b, VEGF or empty (mock) vectors were produced and studied for vascularity, cell proliferation, glucose metabolism and oxygenation. Tumours were evaluated by immunohistochemistry (IHC), flow cytometry, use of radiolabelled markers of energy metabolism ([F-18] FDG) and hypoxia ([F-18] EF5), and intratumoral polarographic measurements of pO(2). Results: Both FGF8b and VEGF tumours grew rapidly in nude mice and showed highly vascularised morphology. Perfusion studies, pO(2) measurements, [F-18] EF5 and [F-18] FDG uptake as well as IHC staining for glucose transport protein (GLUT1) and hypoxia inducible factor (HIF) 1 showed that VEGF xenografts were well-perfused and oxygenised, as expected, whereas FGF8b tumours were as hypoxic as mock tumours. These results suggest that FGF8b-induced tumour capillaries are defective. Nevertheless, the growth rate of hypoxic FGF8b tumours was highly increased, as that of well-oxygenised VEGF tumours, when compared with hypoxic mock tumour controls. Conclusion: FGF8b is able to induce fast growth in strongly hypoxic tumour microenvironment whereas VEGF-stimulated growth advantage is associated with improved perfusion and oxygenation of prostate tumour xenografts
Recommended from our members
Erratum to: 36th International Symposium on Intensive Care and Emergency Medicine: Brussels, Belgium. 15-18 March 2016.
[This corrects the article DOI: 10.1186/s13054-016-1208-6.]
Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study
5-Fluorouracil (5-FU)-based chemotherapy is frequently associated with diarrhoea. We compared two 5-FU-based regimens and the effect of Lactobacillus and fibre supplementation on treatment tolerability. Patients diagnosed with colorectal cancer (n=150) were randomly allocated to receive monthly 5-FU and leucovorin bolus injections (the Mayo regimen) or a bimonthly 5-FU bolus plus continuous infusion (the simplified de Gramont regimen) for 24 weeks as postoperative adjuvant therapy. On the basis of random allocation, the study participants did or did not receive Lactobacillus rhamnosus GG supplementation (1–2 × 1010 per day) and fibre (11 g guar gum per day) during chemotherapy. Patients who received Lactobacillus had less grade 3 or 4 diarrhoea (22 vs 37%, P=0.027), reported less abdominal discomfort, needed less hospital care and had fewer chemotherapy dose reductions due to bowel toxicity. No Lactobacillus-related toxicity was detected. Guar gum supplementation had no influence on chemotherapy tolerability. The simplified de Gramont regimen was associated with fewer grade 3 or 4 adverse effects than the Mayo regimen (45 vs 89%), and with less diarrhoea. We conclude that Lactobacillus GG supplementation is well tolerated and may reduce the frequency of severe diarrhoea and abdominal discomfort related to 5-FU-based chemotherapy
Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice
<p>Abstract</p> <p>Background</p> <p>Metastatic prostate cancer is associated with a high morbidity and mortality but the spreading mechanisms are still poorly understood. The aminobisphosphonate alendronate, used to reduce bone loss, has also been shown to inhibit the invasion and migration of prostate cancer cells <it>in vitro</it>. We used a modified orthotopic PC-3 nude mouse tumor model of human prostate cancer to study whether alendronate affects prostate tumor growth and metastasis.</p> <p>Methods</p> <p>PC-3 cells (5 × 10<sup>5</sup>) were implanted in the prostates of nude mice and the mice were treated with alendronate (0.5 mg/kg/day in PBS, s.c.) or vehicle for 4 weeks. After sacrifice, the sizes of tumor-bearing prostates were measured and the tumors and prostate-draining regional iliac and sacral lymph nodes were excised for studies on markers of proliferation, apoptosis, angiogenesis and lymphangiogenesis, using histomorphometry and immunohistochemistry.</p> <p>Results</p> <p>Tumor occurrence in the prostate was 73% in the alendronate-treated group and 81% in the control group. Mean tumor size (218 mm<sup>3</sup>, range: 96–485 mm<sup>3</sup>, <it>n </it>= 11) in the alendronate-treated mice was 41% of that in the control mice (513 mm<sup>3</sup>, range: 209–1350 mm<sup>3</sup>, <it>n </it>= 13) (<it>p </it>< 0.05). In the iliac and sacral lymph nodes of alendronate-treated mice, the proportion of metastatic area was only about 10% of that in control mice (<it>p </it>< 0.001). Immunohistochemical staining of tumor sections showed that alendronate treatment caused a marked decrease in the number of CD34-positive endothelial cells in tumors (<it>p </it>< 0.001) and an increase in that of ISEL positive apoptotic cells in tumors as well as in lymph node metastases (<it>p </it>< 0.05) compared with those in the vehicle-treated mice. The density of m-LYVE-1-stained lymphatic capillaries was not changed.</p> <p>Conclusion</p> <p>Our results demonstrate that alendronate treatment opposes growth of orthotopic PC-3 tumors and decreases tumor metastasis to prostate-draining lymph nodes. This effect could be at least partly explained by decreased angiogenesis and increased apoptosis. The results suggest that bisphosphonates have anti-tumoral and anti-invasive effects on primary prostate cancer.</p
- …